Fundz

Who to call at Teva Pharmaceutical Industries Ltd, and when

Fundz watches for the moments Teva Pharmaceutical Industries Ltd starts buying, and tells you who to reach.

  • An alert the day Teva Pharmaceutical Industries Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Teva Pharmaceutical Industries Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Teva Pharmaceutical Industries Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept.

Nov 03, 2026

Contract Type

agreement

Tel AvivManufacturingBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Teva Pharmaceutical Industries has entered into a license and commercialization agreement with Samsung Bioepis to gain U.S. rights for biosimilars infliximab-abda and etanercept-ykro. This agreement will enhance Teva’s portfolio in the immunology sector, with manufacturing overseen by Samsung Bioepis and sales managed by Teva.

Company Information

Company

Teva Pharmaceutical Industries Ltd

Location

Tel Aviv, Tel Aviv District, Israel

About

Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of people worldwide. With a focus on innovative medicines, especially in areas of central nervous system, pain, and respiratory therapies, Teva is dedicated to improving health and increasing access to medicines around the world.

Related People

Eric
Senior decision-maker at this company
••••••••@••••••••

See Eric's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Teva Pharmaceutical Industries Ltd's next move

Learn about Strategic plan

Teva Pharmaceutical Industries Ltd signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.